Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

US Patent RE48731 · Granted Sep 14, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CSF-1R inhibitors and methods of use thereof2025
Methods of treating disorders using CSF1R inhibitors2025
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof2025
Anti-viral activity of VPS34 inhibitors2025
Aminopyrimidine amide autophagy inhibitors and methods of use thereof2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naph2025
RAF kinase inhibitors and methods of use thereof2025
Methods of treating disorders using CSF1R inhibitors2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naph2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naph2025
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naph2025
In vitro glycosylation of proteins and enzymes2024